Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C22H21ClN4O3 and a molecular weight of approximately 424.88 g/mol[1][2][5]. It features an imidazole carboxamide core linked to a benzoxazole moiety and a chlorinated phenyl group. The drug is classified as experimental and there is no evidence of clinical approval or established therapeutic use. Its mechanism of action has not been characterized in the literature or major chemical databases[1]. No pharmacological activity or specific biological targets have been reported for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-((1R,2S)-1-{2-[2-(4-chlorophenyl)-1,3-benzoxazol-7-yl]ethyl}-2-hydroxypropyl)-1H-imidazole-4-carboxamide.